S1000 Analyzer Receives Its First Patent from the U.S. Patent Office

Stratedigm, Inc. announced that the U.S patent office issued its first patent for the S1000 opti-symmetric excitation architecture. This unique optical design uses a vertical optical plate with lasers mounted symmetrically to the front and backside of a rigid, unibody module, making the S1000 analyzer the most compact four laser cytometer on the market. Stratedigm’s S1000 analyzer was commercially launched on May of 2008 at the XXIV International Congress of the International Society for Analytical Cytology (ISAC 2008) Budapest, Hungary.   The S1000 cytometer is based on multiple, patent pending technologies for its unique and powerful electronics, excitation optics, emission optics and fluidics architectures.

Menu
×
Menu